Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Option, Activity
The following is a summary of stock option activity during the years ended December 31, 2021 and 2020:
Number of
options
outstanding		 Weighted
average
exercise
price (*)		 Average
remaining
contractual life
(in years)		 Aggregate
intrinsic value
(in thousands)
(**)
Outstanding – December 31, 2019 297,560  $ —  7.6 $ 81 
Options granted 214,182  0.28 
Options exercised (45,000) — 
Outstanding – December 31, 2020
 466,742  $ 0.14  8.2 $ 81 
Options granted
 679,495  3.22 
Forfeitures
 (5,453) 0.07 
Options exercised
 (34,846) — 
Outstanding – December 31, 2021
 1,105,938  2.03  8.8 1,535 
Exercisable – December 31, 2021
 346,096  $ 0.57  7.3 $ 878 

(*) $ - Indicates exercise price less than $0.01 per share
(**) Intrinsic value is based on the fair market value of the Company's common stock.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions For the years ended December 31, 2021 and 2020, the assumptions used in the Black-Scholes option pricing model, which was used to estimate the grant date fair value per option, were as follows:
Year ended December 31,
2021 2020
Weighted-average Black-Scholes option pricing model assumptions:
Volatility
90.01% - 106.22%
74.61% - 74.89%
Expected term (in years)
5.69 - 5.93
5.55 - 5.87
Risk-free rate
0.69% - 1.08%
0.25% - 0.39%
Expected dividend yield $ —  $ — 
Weighted average grant date fair value per share
$2.07 - 3.44
$0.16 - 0.18
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following is a summary of stock-based compensation expense:
Year ended December 31,
2021 2020
General and administration $ 164,933  $ 5,846 
Research and development 27,376  3,850 
$ 192,309  $ 9,696 
Schedule of Nonvested Restricted Stock Units Activity The following is a summary of non-vested RSUs award activity for the year ended December 31, 2021, we had no such activity in 2020:
Number of Shares Weighted Average Grant Date Fair Value
Non-vested 30,000  $ 3.20